Leading pharma companies conspire to keep drug price in the U.S. far higher than a free market would support — and that also stifles innovation, says the author of a new book.
Leading pharma companies conspire to keep drug price in the U.S. far higher than a free market would support — and that also stifles innovation, says the author of a new book.
The Joseph H. Lauder Institute
256 South 37th street
2nd Floor
Philadelphia, PA 19104-6330